# Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9

> **NCT00582608** · NA · TERMINATED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 12 (actual)

## Conditions studied

- CNS Cancer
- Neuroblastoma
- Sarcoma

## Interventions

- **DRUG:** 131I-8H9
- **DRUG:** 8H9

## Key facts

- **NCT ID:** NCT00582608
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-10
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2017-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00582608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00582608, "Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT00582608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*